Tumor Budding as a Prognostic Marker in Primary Colon Cancer – A Single Center Experience

1 Jemal A, Bray F, Center MM, et al. Global Cancer Statistics. CA Cancer J Clin. 2011; 61: 69–90. Search in Google Scholar

2 Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71: 209–49. Search in Google Scholar

3 Aleksandrova K, Pischon T, Jenab M, et al. Combined Impact of Healthy Lifestyle Factors on Colorectal Cancer: A Large European Cohort Study. BMC Med. 2014; 12(1): 1-15. Search in Google Scholar

4 Edge SB and Compton CC. The American Joint Committee on Cancer: The 7th edition of the AJCC Cancer Staging Manual and the future of TNM. Ann Surg Oncol. 2010; 17: 1471-1474. Search in Google Scholar

5 Benson AB, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004; 22: 3408-3419. Search in Google Scholar

6 Argilés G, Tabernero J, Labianca R, et al. Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. Ann Oncol. 2020; 31(10): 1291-1305. Search in Google Scholar

7 Labianca R, Nordlinger B, Beretta GD, et al. Early Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up. Ann Oncol. 2013; 24(Suppl 6): vi64-72. Search in Google Scholar

8 Marshall JL. Risk Assessment in Stage II Colorectal Cancer. Oncology (Williston Park). 2010; 24: 9-13. Search in Google Scholar

9 Lugli A, Karamitopoulou E and Zlobec I. Tumour Budding: A Promising Parameter in Colorectal Cancer. Br J Cancer. 2012; 106: 1713-1717. Search in Google Scholar

10 Mitrovic B, Schaeffer DF, Riddell RH, et al. Tumor Budding in Colorectal Carcinoma: Time to Take Notice. Mod Pathol. 2012; 25: 1315-1325. Search in Google Scholar

11 van Wyk HC, Park J, Roxburgh C, et al. The Role of Tumour Budding in Predicting Survival in Patients with Primary Operable Colorectal Cancer: A Systematic Review. Cancer Treat Rev. 2015; 41: 151-159. Search in Google Scholar

12 Lugli A, Kirsch R, Ajioka Y, et al. Recommendations for Reporting Tumor budding in Colorectal Cancer Based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017; 30(9): 1299-1311. Search in Google Scholar

13 Ueno H, Ishiguro M, Nakatani E, et al. Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results from the SACURA Trial. J Clin Oncol. 2019; 37(22): 1886–1894. Search in Google Scholar

14 Prall F. Tumour Budding in Colorectal Carcinoma. Histopathology. 2007; 50(1): 151-62 311. Search in Google Scholar

15 Rogers AC, Winter DC, Heeney A, et al. Systematic Review and Meta-analysis of the Impact of Tumour Budding in Colorectal Cancer. Br J Cancer. 2016; 115(7): 831-840. Search in Google Scholar

16 Hase K, Shatney C, Johnson D, et al. Prognostic value of tumor “budding” in patients with colorectal cancer. Dis Colon Rectum. 1993; 36(7): 627-35. Search in Google Scholar

17 Roh MS, Lee JI, and Choi PJ. Tumor Budding as a Useful Prognostic Marker in Esophageal Squamous Cell Carcinoma. Dis Esophagus. 2004; 17(4): 333-337. Search in Google Scholar

18 Karamitopoulou E, Zlobec I, Born D, et al. Tumour Budding is a Strong and Independent Prognostic Factor in Pancreatic Cancer. Eur J Cancer. 2013; 49(5): 1032-1039. Search in Google Scholar

19 Liang F, Cao W, Wang Y, et al. The Prognostic Value of Tumor Budding in Invasive Breast Cancer. Pathol Res Pract. 2013; 209(5): 269-275. Search in Google Scholar

20 Luo WR, Gao F, Li SY, et al. Tumour Budding and the Expression of Cancer Stem Cell Marker Aldehyde Dehydrogenase 1 in Nasopharyngeal Carcinoma. Histopathology. 2012; 61(6): 1072-1081. Search in Google Scholar

21 Kadota K, Yeh YC, Villena-Vargas J, et al. Tumor budding correlates with the protumor immune microenvironment and is an independent prognostic factor for recurrence of stage I lung adenocarcinoma. Chest. 2015; 148(3): 711-721. Search in Google Scholar

22 Koyuncuoglu M, Okyay E, Saatli B, et al. Tumor Budding and E-Cadherin Expression in Endometrial Carcinoma: Are They Prognostic Factors in Endometrial Cancer? Gynecol Oncol. 2012; 125(1): 208-213. Search in Google Scholar

23 Saito K, Okuyama T, Miyazaki S, et al. Tumor budding as a predictive marker of relapse and survival in patients with stage II colon cancer. In vivo. 2022 Jul 1; 36(4): 1820-1828. Search in Google Scholar

24 Koelzer VH, Assarzadegan N, Dawson H, et al. Cytokeratin-based Assessment of Tumour Budding in Colorectal Cancer: Analysis in Stage II Patients and Prospective Diagnostic Experience. J Pathol Clin Res. 2017; 3(3): 171-178. Search in Google Scholar

25 Prall F, Ostwald C, and Linnebacher M. Tubular Invasion and the Morphogenesis of Tumor Budding in Colorectal Carcinoma. Hum Pathol. 2009; 40(10): 1510-1512. Search in Google Scholar

26 Prall F, Nizze H, and Barten M. Tumour Budding as Prognostic Factor in Stage I/II Colorectal Carcinoma. Histopathology. 2005; 47(1): 17-24. Search in Google Scholar

27 Basile D, Broudin C, Emile JF, et al. Tumor Budding is an Independent Prognostic Factor in Stage III Colon Cancer Patients: A Post-hoc Analysis of the IDEA-France Phase III Trial (PRODIGE-GERCOR). Ann Oncol. 2022; 33(6): 628-637. Search in Google Scholar

28 Ueno H, Murphy J, Jass JR, et al. Tumour ‘Budding’ as an Index to Estimate the Potential of Aggressiveness in Rectal Cancer. Histopathology. 2002; 40: 127-132. Search in Google Scholar

29 Graham RP, Vierkant RA, Tillmans LS, et al. Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort. Am J Surg Pathol. 2015; 39: 1340-1346. Search in Google Scholar

30 Smit M, van Pelt G, Roodvoets A, et al. Uniform noting for international application of the tumor-stroma ratio as an easy diagnostic tool: protocol for a multicenter prospective cohort study. JMIR Res 2019; Protoc 8: e13464. https://doi.org/10.2196/13464 Search in Google Scholar

31 Smit M vPG, Tollenaar R, Mesker W Uniform noting for international application of the tumour-stroma ratio as easy diagnostic tool (UNITED) study website. http://watchstroma.com/. Accessed 27 July 2020 Search in Google Scholar

32 Marloes AS, Gabi W van P, Valeska T, et al. Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study. Intern J Colorectal Disease (2021) 36:2729–2737 Search in Google Scholar